Sudeep Pharma is a technology-led manufacturer of excipients and specialty ingredients serving the pharmaceutical, food and nutrition industries. It has a strong presence across domestic and international markets, including the United States, South America, Europe, the Middle East, Africa and the Asia-Pacific region. As of June 30, 2025, the Company operates three manufacturing facilities in Vadodara, Gujarat, and, following the acquisition of NSS as a Material Subsidiary effective May 22, 2025, also operates a manufacturing facility in Ireland. The Company continues to strengthen its capabilities through ongoing investments in research and development
Price Band₹563 - ₹593 |
Dates21 Nov - 25 Nov |
GMP₹91 (15.35%) |
Subscriptions93.72 times |
Issue Size₹895.00 Crs |
Sudeep Pharma IPO Objects
- Capital expenditure towards procurement of machinery for the production line located at Nandesari Facility .
- General corporate purpose
Sudeep Pharma IPO Details
Price Band₹563 - ₹593 |
Listing AtNSE & BSE |
IPO Issue Type100% Book Built Offer |
Fresh Issue₹95.00 Cr (0.16 Cr Shares) |
Offer For Sale₹800.00 Cr (1.35 Cr Shares) |
Total Issue₹895.00 Cr (1.51 Cr Shares) |
Face Value₹1 per equity share |
Sudeep Pharma IPO Lot Information
| Investor Category | Lot | Shares | Amount | |
|---|---|---|---|---|
| Retail |
Minimum
1
25
14,825
Maximum
13
325
1,92,725
|
|||
| Small HNI |
Minimum
14
350
2,07,550
Maximum
67
1,675
9,93,275
|
|||
| Big HNI |
Minimum
68
1,700
10,08,100
|
|||
Sudeep Pharma IPO Subscription
Updated as on 25-Nov-2025 19:00:00
| Investor Category | Subscription (times) | Shares Offered | Shared Bid |
|---|---|---|---|
| QIB | 213.08 | 30,18,550 | 64,31,88,450 |
| NII | 116.72 | 22,63,913 | 26,42,40,450 |
| bNII (bids above ₹10L) | 134.91 | 15,09,276 | 20,36,19,700 |
| sNII (bids between ₹2L to ₹10L) | 80.33 | 7,54,637 | 6,06,20,750 |
| Retail | 15.65 | 52,82,463 | 8,26,71,250 |
| Total | 93.72 | 1,05,64,926 | 99,01,00,150 |
Sudeep Pharma IPO GMP
The estimated Grey Market Premium of Sudeep Pharma IPO is ₹91 per share (15.35%)
Category Allocation
| Particulars | Allocation |
|---|---|
| QIBs | Not more than 50% of Net Offer |
| Big HNIs (NII) | Not less than 10% of Net Offer |
| Small HNIs (NII) | Not less than 5% of Net Offer |
| Retail | Not less than 35% of Net Offer |
Sudeep Pharma IPO Financials
| Particulars | Jun-25 | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|---|
| Revenue from Operations | 124.92 | 502.00 | 459.28 | 428.74 |
| Profit after Tax | 31.27 | 138.69 | 133.19 | 62.32 |
| Net Worth | 688.32 | 497.53 | 359.11 | 226.29 |
| Total Borrowing | 135.97 | 135.25 | 75.03 | 82.26 |
| Total Assets | 922.26 | 717.17 | 513.87 | 420.11 |
| NAV per share (in ₹) | 62.61 | 45.86 | 33.10 | 20.86 |
| EPS - Basic (in ₹) | 2.80 | 12.78 | 12.28 | 5.74 |
The financial information presented is on a consolidated basis.
Key Performance Indicators
| KPI | VALUES |
|---|---|
| EBITDA | 39.70% |
| PAT | 27.63% |
| ROE | 28.13% |
| ROCE | 29.82% |
| Net Debt to Equity | 0.20 |
| PE Ratio | 46.40 |
| PB Ratio | 12.93 |
| Mkt Cap (in Crs.) | 6,697.85 |
- All the data pertains to FY 2024-25.
- PE, PB, and market capitalization are calculated based on the Upper Price Band.
Sudeep Pharma IPO Peer Comparision
There are no comparable listed peers in India!
Sudeep Pharma IPO Peer Comparision
There are no comparable listed peers in India!
Promoter Details
| Name | Shareholding |
|---|---|
| Riva Resources Private Limited | 40.93% |
| Sujit Bhayani | 24.67% |
| Shanil Bhayani | 5.19% |
| Avani Bhayani* | 5.22% |
| Sujeet Bhayani | 13.36% |
| Total | 89.37% |
Management Details
| Name | Designation |
|---|---|
| Sujit Bhayani | Chairman & MD |
| Ketan Vyas | CFO |
Company Details
Name: Sudeep Pharma Limited
Address: 129/1/A, GIDC Estate, Nandesari, Vadodara – 391340, Gujarat, India
Number: +91 265 284 0656
Email: cs.sudeep@sudeepgroup.com
Website: https://www.sudeeppharma.com
Book Running Lead Managers (BRLMs)
ICICI Securities
Visit Website
IIFL Capital Services
Visit WebsiteRTAs
MUFG Intime India
Visit WebsiteFrequently Asked questions?
Find answers to common questions that come in your mind related to IPO.
Sudeep Pharma IPO is a Mainboard IPO having an issue size of Rs. ₹895.00 Crs. Sudeep Pharma IPO is priced at ₹563 - ₹593 per share. The issue opens on 21 Nov 25 and closes on 25 Nov 25.
Sudeep Pharma IPO opens on 21 Nov 25 and closes on 25 Nov 25.
The estimated Grey Market Premium of Sudeep Pharma IPO is ₹91 per share (15.35%).
The minimum lot size of Sudeep Pharma IPO is 25 shares & the minimum application amount is Rs. 14825.
The allotment date of Sudeep Pharma IPO is 26 Nov 25.
The listing date of Sudeep Pharma IPO is 28 Nov 25.
Sudeep Pharma IPO is subscribed 93.72 times.
Sudeep Pharma IPO is priced at ₹563 - ₹593 per share.
Click the allotment link on Sudeep Pharma IPO page of IPO360.
- Go to Kite App → Tap on Bids → Tap on IPO
- Select the IPO → Tap on apply → Enter UPI ID
- Enter Qty and Price
- Submit the application
- Approve the UPI Mandate on your UPI app
- Go to Groww App → Stocks Section → Select IPO option
- Select the IPO you want to apply
- Enter your bid details and price
- Enter UPI ID & submit
- Approve the UPI Mandate on your UPI app
- Log in to your bank's net banking portal.
- Navigate to the 'IPO' or 'ASBA' section.
- Select Sudeep Pharma IPO from the list of available IPOs.
- Enter the required details: Bid quantity, Price, DP ID & Client ID, etc
- Submit the application.
- Money will remain blocked till the refund date
We are a one-stop destination for all your IPO needs. Get reliable, accurate, and timely information for all the IPOs in India!